Security key
14161Y200
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
CUSIP: 14161Y200
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Class A Common Shares
- Total 13F shares
- 5,387,006
- Total 13F value
- $8,272,481
- Share change
- -415,974
- Put/Call ratio
- 6.4%
- SEC-reported price per share
- $1.54
- Number of holders
- 26
- Value change
- -$917,566
- Number of buys
- 14
- Number of sells
- 14
- Shares outstanding
- 117,675,173
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
26
Top holders
10
CRDL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14161Y200
Recent filing periods:
Ownership snapshot
Top reported holders of CRDL - Cardiol Therapeutics Inc. - Class A Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MMCAP International Inc. SPC
Disclosed value leader
MMCAP International Inc. SPC
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 2.7%
Showing 1-6 of 15 holder rows.
Quick read
MMCAP International Inc. SPC leads the comparable SEC ownership view at 2.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MMCAP International Inc. SPC's linked filing trail.
Comparable ownership
Top 5
MMCAP International Inc. SPC
2.7%
Mirae Asset Global Investments Co...
0.89%
Verition Fund Management LLC
0.39%
TWO SIGMA INVESTMENTS, LP
0.17%
CITADEL ADVISORS LLC
0.15%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC |
13F
Company
|
2.7%
|
$5,833,000
3,153,200 shares
|
— | 31 Dec 2021 |
| Mirae Asset Global Investments Co., Ltd. |
13F
Company
|
0.89%
|
$1,928,000
1,045,205 shares
|
— | 31 Dec 2021 |
| Verition Fund Management LLC |
13F
Company
|
0.39%
|
$847,000
457,732 shares
|
— | 31 Dec 2021 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.17%
|
$360,000
194,554 shares
|
— | 31 Dec 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.15%
|
$328,000
177,069 shares
|
— | 31 Dec 2021 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.11%
|
$233,000
126,100 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
5,387,006
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2022 Across Filers
Q1 2022 holders
26
Q1 2022 holders
26
Holder diff
0
| Investor | Q1 2022 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend